⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2390664 | 0.89 | — | — | |
| SCHEMBL238943 | 0.73 | NPC1 (0.33) | — | |
| SCHEMBL238978 | 0.72 | — | — | |
| SCHEMBL1358657 | 0.70 | ALDH1A1 (0.34) | — | |
| SCHEMBL9596829 | 0.69 | ALDH1A1 (0.33) | — | |
| SCHEMBL7782028 | 0.68 | — | — | |
| SCHEMBL7109983 | 0.66 | — | — | |
| SCHEMBL623051 | 0.64 | MAPK1 (0.35) | — | |
| SCHEMBL1705145 | 0.63 | TP53 (0.33) | — | |
| SCHEMBL3875145 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250114489-A1 | MASKED IL12 PROTEIN | TAGWORKS PHARMACEUTICALS B.V. (NL) | 2025-04-10 | — | — | US | disclosed |
| EP-4372000-A2 | MASKED IL12 PROTEIN | Tagworks Pharmaceuticals B.V. (NL) | 2024-05-22 | — | — | EP | disclosed |
| EP-4314031-B1 | MASKED IL12 PROTEIN | TAGWORKS PHARMACEUTICALS B V (NL) | 2024-03-13 | — | — | EP | disclosed |
| EP-4314031-A1 | MASKED IL12 PROTEIN | Tagworks Pharmaceuticals B.V. (NL) | 2024-02-07 | — | — | EP | disclosed |
| WO-2023158305-A1 | MASKED IL12 PROTEIN | TAGWORKS PHARMACEUTICALS B.V. (NL) | 2023-08-24 | — | — | WO | disclosed |
| US-8188139-B2 | Heterocyclic-substituted phenyl methanones | HOFFMAN-LA ROCHE INC. (US) | 2012-05-29 | — | — | US | disclosed |
| US-8163766-B2 | Beta-secretase modulators and methods of use | AMGEN INC. (US) | 2012-04-24 | — | — | US | disclosed |
| US-20110118250-A1 | BETA-SECRETASE MODULATORS AND METHODS OF USE | AMGEN INC. (US) | 2011-05-19 | — | — | US | disclosed |
| US-7872009-B2 | Beta-Secretase modulators and methods of use | AMGEN INC. (US) | 2011-01-18 | — | — | US | disclosed |
| US-7786135-B2 | Substituted pyrroline kinase inhibitors | JANSSEN PHARMACEUTICA, N.V. (BE) | 2010-08-31 | — | — | US | disclosed |
| EP-0856002-B1 | PHENYLOXAZOLIDINONES HAVING A C-C BOND TO 4-8 MEMBERED HETEROCYCLIC RINGS | UPJOHN CO (US) | 2001-10-24 | — | — | EP | disclosed |
| US-6166056-A | Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings | PHARMACIA (US) | 2000-12-26 | — | — | US | disclosed |
| US-6051716-A | ANTIMICROBIAL AGENTS | PHARMACIA & UPJOHN, INC. (US) | 2000-04-18 | — | — | US | disclosed |
| US-6043266-A | MICROBIOCIDES TREATING GRAM-POSITIVE BACTERIA INFECTIONS AND PERSONS WITH AIDS | PHARMACIA & UPJOHN COMPANY (US) | 2000-03-28 | — | — | US | disclosed |
| US-5968962-A | ANTIMICROBIAL AGENTS; EFFECTIVE AGAINST GRAMPOSITIVE BACTERIA | PHARMACIA & UPJOHN COMPANY (US) | 1999-10-19 | — | — | US | disclosed |
| EP-0856002-A1 | PHENYLOXAZOLIDINONES HAVING A C-C BOND TO 4-8 MEMBERED HETEROCYCLIC RINGS | PHARMACIA & UPJOHN COMPANY (US) | 1998-08-05 | — | — | EP | disclosed |
| US-5635501-A | Alphalosporins and 1-carba-1-dethia cephalosporins | PFIZER INC. (US) | 1997-06-03 | — | — | US | disclosed |
| WO-1997009328-A1 | PHENYLOXAZOLIDINONES HAVING A C-C BOND TO 4-8 MEMBERED HETEROCYCLIC RINGS | PHARMACIA & UPJOHN COMPANY (US) | 1997-03-13 | — | — | WO | disclosed |
| EP-0647230-A1 | CEPHALOSPORINS AND 1-CARBA-1-DETHIA CEPHALOSPORINS | PFIZER INC. (US) | 1995-04-12 | — | — | EP | disclosed |
| WO-1994000457-A1 | ALPHALOSPORINS AND 1-CARBA-1-DETHIA CEPHALOSPORINS | SMITHKLINE BEECHAM P.L.C. (GB) | 1994-01-06 | — | — | WO | disclosed |